About vivitide
vivitide is a company based in Gardner (United States) founded in 1983 was acquired by Biosynth Carbosynth in March 2022. The company has 94 employees as of December 31, 2021. vivitide operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Rameda, among others.
- Headquarter Gardner, United States
- Employees 94 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name New England Peptide, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
94
as on Dec 31, 2021
-
Acquired by
Biosynth Carbosynth
(Mar 17, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of vivitide
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of vivitide
Detailed funding history for vivitide
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in vivitide
vivitide has secured backing from 1 investor. Prominent investors backing the company include Biosynth Carbosynth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of drug discovery, manufacturing, supply chain, regulatory support, and other services
|
Locked | Locked | Locked |
Investor details for vivitide
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by vivitide
Investment portfolio details for vivitide
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - vivitide
Detailed financials for vivitide
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vivitide Comparisons
Peer comparison for vivitide
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of vivitide
vivitide operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm, Ocelot Bio and Rameda, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
Ocelot Bio is a CDMO specializing in peptide manufacturing services.
|
|
| Locked | Locked | Locked |
Developer and manufacturer of generic pharmaceuticals, nutraceuticals, food supplements and veterinary products
|
|
| Locked | Locked | Locked |
Drug R&D services for cardiovascular and metabolic diseases are provided.
|
Detailed competitors of vivitide
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vivitide
Complete news archive for vivitide
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about vivitide
vivitide was founded in 1983.
vivitide is headquartered in Gardner, United States. It is registered at Gardner, Massachusetts, United States.
Martina Diekmann is the current CEO of vivitide.
As of Dec 31, 2021, the latest employee count at vivitide is 94.
Vivitide was founded in 1983 and is based in Gardner, United States. Services in the biotechnology sector are offered, focusing on drug development for neoantigen peptides and antibodies. Operations include peptide synthesis and antibody production to support pharmaceutical research. The company serves clients in the immuno-oncology field through specialized laboratory processes and expertise in custom biomolecule development.
vivitide's top competitors include Enzene Biosciences, Hybio Pharmaceutical and PolyPeptide.
vivitide has 1 investor. Key investors include Biosynth Carbosynth.